Navigation Links
Reach Of The Morning-After Pill Treatment Inadequate Among Sexual Assault Victims

Activists, medical experts and counselors have urged the Ontario Government to launch a programme to ensure provision of drug treatment// to all victims of sexual assault, who might have been exposed to the HIV/AIDS virus. // The cost associated with this drug treatment ($1,200) has resulted in a limited availability of this therapy (combination therapy using Combivir and Kaletra).

Very little effort is being done to promote the availability of this potential life saving therapy amongst the general public, according to Llewellyn Goddard, an active member of the Toronto's People with AIDS Foundation. "There are gaps in terms of health campaigns out there and PEP (post-exposure prophylaxis) is one of them", said Watchorn, one of the health officials.

This form of treatment has been offered to health care workers since 1990. The pressure exerted by sexual assault centers and members of the medical community ensured availability of the treatment at more than 24 regional sex assault centers. In order for the treatment to be effective, it has to be offered within 72 hours of the incident.

This however would not have been possible if not for the joint study conducted by the Ontario Women's Health Council and the Centre for Research in Women's Health. It is further hoped that this facility can be made available to all sexual assault victims if it were to be funded universally.

The treatment, commonly known as morning-after pill for exposure to HIV, should be used in cases of known HIV exposure for a period of 28 days. If this information is not known, offering the treatment is largely based on the discretion of the attending physician. While doing so, it is equally important for the doctor to assess the risk associated with an encounter and to discuss the advantages and disadvantages with the patient, thereby enabling them take an informed decision.

If instituted within the stipulated time, has been f ound to reduce the risk of transmission by as much as 80%. Nausea, fatigue and diarrhea represent some of the most commonly seen side effects. Liver damage and severe skin reactions can be manifested in severe cases. It is possible to reverse the side effects or attenuate the same by adjusting the dose of the medication or the drug combinations.

A majority of victims who take the treatment however, discontinue the same, prompting concerns regarding the development of immunity to the currently used anti-retroviral drugs.

The probability of transmission of HIV during one episode of sexual contact episode is about 0.1 to 1%. The risk is even greater if either partner has a diagnosis of HIV infection. If such an individual has anal sex, the risk of transmission to the partner is as high as 3%. This is much lesser than the probability of HIV transmission due to sharing needles or syringes (<1%).

A legal case filed by a gay couple in Britain recently has sparked an international debate on whether or not governments can be held responsible for not fully adopting this treatment regimen to fight against the spread of this deadly disease. The lack of transparency regarding the use of the medication related to a condom accident is believed to have ignited the fire.

While the above issue is controversial, it is reasonable to show interest in the prophylactic measures to be instituted soon after an episode of sexual assault, based on a personal motive to prevent contraction of HIV or other such diseases.


'"/>




Related medicine news :

1. Heart Attack Patients Reaching Hospital During Off-Hours Have Increased Risk Of Death
2. Birds Flu Scare Reaches Germany
3. LASIK Treatments Still To Reach Common Man
4. Number Of Bird Flu Cases In Switzerland Reaches 11
5. Cholera Death Toll Reaches 1,156 in Angola
6. Indonesia’s Bird Flu Death Toll Reaches 3
7. Growth Factors Help Neurons to Reach Their Correct Destination
8. Subsidies For GPs Visits : Agreement Reached
9. Latest Drug for AMD, Beyond The Reach Of Common Man
10. Medical Course in Kerala is Beyond the Reach of NRIs
11. Indonesias Bird Flu Death Toll Reaches 42
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... , ... March 23, 2017 , ... ... audit software solution, iCode Assurance, at HCCA’s 21st annual Compliance Institute on March ... the coding audit process for all medical chart types with a comprehensive set ...
(Date:3/23/2017)... ... , ... “Wounded Woman Be Ye Healed-Passing On A Legacy”: a call to ... the creation of published author, Desiree M Webb, a registered nurse, minister of music, ... happily married to her husband, Paul, for over twenty-nine years. Desiree enjoys writing, ...
(Date:3/23/2017)... ... March 23, 2017 , ... “A Respectful Response To Atheist ... To Atheist Manifesto” is the creation of published author Richard Hostetter, a former ... years. He holds graduate degrees from Kent State University and the University of ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... today announced the publication of “Profiling protein expression in circulating tumor cells using ... publication describes the use of the Vortex technology to capture CTCs ...
(Date:3/22/2017)... ... 2017 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had won the ‘Clinical Supply Chain Excellence’ category ... International Exhibition & Convention Centre, Singapore. The award was presented at the conference ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... Inc. today announced the appointment of Martyn Coombs as ... of ImaginAb, said "At ImaginAb we have exciting science and technology. ... our business, particularly in commercializing and making step changes in the ... realize our potential." ... Mr. Coombs is a recognized industry leader in nuclear medicine and ...
(Date:3/22/2017)... N.J. , March 22, 2017  CANTEL MEDICAL CORP. ... B. Hansen , President and CEO, will be presenting at ... at the Westin Grand Central Hotel in New ... April 5, 2017 at 3:00 p.m. ET. In addition, management ... A live audio webcast will be available ...
(Date:3/22/2017)... 22, 2017 Research and Markets has ... Inhibitors Market & Clinical Pipeline Insight 2022" drug pipelines ... ... Clinical Pipeline Insight 2022 report gives comprehensive insight on clinical ... immune check point inhibitors as main streamline drugs in the ...
Breaking Medicine Technology: